Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
BJU International|March 24, 2007
Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UKPhilip D Kell, Kyle Hvidsten, Steven V Morant, et al.Managed Care Interface|December 2, 2006
The economic effect of switching from sildenafil to another phosphodiesterase type 5 inhibitorJames P Harnett, Trent P McLaughlin, John P Mulhall, et al.The Journal of Sexual Medicine|January 21, 2006
Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunctionJohn P Mulhall, Trent P McLaughlin, James P Harnett, et al.Pharmacoepidemiology and Drug Safety|September 2, 2005
Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infectionsJon P Furuno, Joshua P Metlay, James P Harnett, et al.Psychiatric Services (Washington, D.C.)|September 3, 2010
Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatientsChristoph U Correll, Benjamin G Druss, Ilise Lombardo, et al.Pageof 1